Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.
Latest website image capture
Clouds background image

Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T20:42:07.000Z thumbnail image
  6. Check
    12 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a modification in the dose of pegylated liposomal doxorubicin (PLD) in the chemo-immunotherapy regime for endocrine-resistant breast cancer patients. This change may impact the treatment response rates and safety profile of the combined therapy involving PLD and pembrolizumab.
    Difference
    0.1%
    Check dated 2024-06-06T14:18:08.000Z thumbnail image
  7. Check
    27 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for participants, including specific health conditions and prior treatments required for inclusion in the study. This change offers more comprehensive information about the requirements for potential participants in the clinical trial.
    Difference
    38%
    Check dated 2024-05-22T19:44:29.000Z thumbnail image
  8. Check
    48 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention possibly related to medical and healthcare publications and documentation.
    Difference
    0.6%
    Check dated 2024-05-01T17:58:22.000Z thumbnail image

Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.